Company Quick10K Filing
JiaLiJia Group
10-Q 2019-09-30 Filed 2020-01-15
10-Q 2019-07-31 Filed 2019-11-01
10-Q 2019-04-30 Filed 2019-06-14
10-K 2019-01-31 Filed 2019-05-07
10-Q 2018-10-31 Filed 2018-12-14
10-Q 2018-07-31 Filed 2018-09-14
10-Q 2018-04-30 Filed 2018-06-13
10-K 2018-01-31 Filed 2018-05-15
10-Q 2017-10-31 Filed 2017-12-20
10-Q 2017-07-31 Filed 2017-09-19
10-Q 2017-04-30 Filed 2017-06-19
10-K 2017-01-31 Filed 2017-05-16
10-Q 2016-10-31 Filed 2016-11-28
10-Q 2016-07-31 Filed 2016-09-02
10-Q 2016-04-30 Filed 2016-06-07
8-K 2020-03-30
8-K 2019-08-29
8-K 2019-07-22
8-K 2019-07-10
8-K 2019-04-09
8-K 2019-01-15
8-K 2019-01-04
8-K 2018-12-18

JiaLiJia Group Financials

RZZN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703,462,000 4,932,953,000 139,834,000 0 -9,707,897,000 -9,659,520,000 -395,458,000
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240,249,000 43,296,964,000 1,764,009,000 374,238,000 -25,717,337,000 -18,297,230,000 -540,256,000
Poverty Dignified (POVD) 0.0 -4,053% 49,338,000 3,079,595,000 0 0 -1,999,816,000 -1,786,224,000 -40,929,000
Zhong Ya (WLUC) 0.0 0 62,889,000 0 0 -561,596,000 -561,596,000 -2,000
Weyland Tech (WEYL) 18% 2.2 -24% 11,699,111,000 2,217,605,000 24,630,065,000 4,371,806,000 -2,778,623,000 -2,702,174,000 -5,820,631,000
Longbau (LNGB) 4% -1.0 2% 10,659,548,000 10,135,830,000 4,882,008,000 209,757,000 164,602,000 221,914,000 -232,744,000
Scandium International Mining (SCY) 0.1 -171% 956,938,000 303,212,000 0 0 -1,636,126,000 -1,634,396,000 -219,146,000
Aprea Therapeutics (APRE) 8.4 -11% 57,336,058,000 9,942,725,000 0 0 -6,249,419,000 -6,249,419,000 -52,334,104,000
IntelliSense Solutions (INLL) 0.0 -7,286% 2,442,000 272,894,000 0 0 -177,936,000 -163,709,000 -2,444,000
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000,000,000 403,121,000,000,000 37,348,000,000,000 0 4,559,000,000,000 4,960,000,000,000 -8,986,000,001,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4,412,000 323,686,000 0 0 -28,634,000 -17,937,000 -4,414,000
Ando Holdings (ANDO) 1.1 -74% 73,214,000 159,843,000 0 0 -54,299,000 -53,972,000 -60,816,000
Po Yuen Cultural (POYE) 0.0 -1,973% 1,000,000 68,122,000 0 0 -19,731,000 -19,731,000 -2,000
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218,459,000 6,588,633,000 0 0 -701,078,000 -701,078,000 -10,879,000
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,577,822,000 65,986,000 14,700,000 0 -314,665,000 -314,640,000 -238,429,000
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130,000,000 54,472,808,000,000 0 0 132,964,000,000 1,095,234,000,000 32,380,960,999,000
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,276,504,000 5,549,239,000 -688,891,000 1,137,086,000 -4,981,415,000
Original Source Music (OSMU) 0.0 743,400% 35,313,000 0 0 -7,434,000 -7,434,000 -2,000
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076,020,000 1,126,459,000 0 0 0 4,713,000 -2,000
JiaLiJia Group (RZZN) 0.0 -1,721% 4,000,000 139,328,000 0 0 -68,826,000 -68,826,000 -2,000

Balance Sheet ($)2016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Cash3,426,00024,503,00016,973,00000000000000
Accounts Receivable
Inventory
PP&E2,500,0002,292,0002,084,000
Assets5,926,00026,795,00019,057,0000000000010,000,0007,000,0004,000,000
Accounts Payable3,570,000765,00012,626,00010,121,0002,773,000200,0000582,000
Long-Term Debt
Liabilities4,612,0001,042,0001,042,000765,00016,680,00020,381,00026,140,00031,332,00037,307,00045,653,00053,265,00084,115,000103,465,000139,328,000
Stockholders' Equity-765,000-16,680,000-20,381,000-26,140,000-31,332,000-37,307,000-45,653,000-53,265,000-74,115,000-96,465,000-135,328,000
Income Statement ($)2016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Revenue5,100,00000000000000
Cost of Revenue3,570,0000000000000
Gross Profit1,530,00000000000000
R&D
SG&A15,915,0003,701,0005,759,0005,192,0005,975,0008,345,0007,613,00022,350,00038,863,000
Tax000000000
Net Income-3,704,000-1,261,000-7,738,000-18,780,000-15,915,000-11,878,000-5,759,000-5,192,000-5,975,000-8,345,000-7,613,000-22,350,000-38,863,000
Cash Flow ($)2016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-31
Cash Operating-134,000-4,623,000-7,530,000-15,931,000-4,054,000-6,206,000-13,107,000-7,765,000-6,175,000-7,764,000-5,444,000-19,150,000-25,238,000
Cash Investing-2,500,00000000000
Cash Financing025,700,0000-1,042,0004,054,0006,206,00013,106,0007,766,0006,175,0007,764,0005,444,00019,150,00025,238,000